There is a known metabolic defect in cardiometabolic disease this was highlighted most recently by Lefer et al., who showed that an impairment in the sulfurome is a hallmark feature of cardiometabolic disease
Ortiz, The risk for urinary tract infections with sodium-glucose cotransporter 2 inhibitors: no longer a cause of concern
When I first started my GLP-1 medication, I expected some changesless appetite, maybe some weight lossbut what I didnt expect was how quickly dehydration would sneak up on me
Complexity increases with additional stack components, requiring careful attention to interactions, timing, and individual response assessment
Is retatrutide available yet
Before Ozempic (semaglutide) hit the market, it underwent rigorous testing in multiple phase III clinical trials